Un antibiotic folosit pentru infecții grave, sub semnul întrebării: ce riscuri poate genera

Cefepime, an antibiotic for severe infections, raises safety concerns based on a study of over 22,000 patients. While the study does not recommend withdrawing the drug, it calls for a reevaluation of its usage. The analysis revealed a higher mortality rate among patients treated with cefepime compared to those receiving other beta-lactam antibiotics. The risk was particularly pronounced in adults and patients with febrile neutropenia. Researchers suggest that dosing challenges may contribute to these outcomes. They emphasize the need for careful interpretation of the results and further research on cefepime's safety and efficacy.